Beth Wolff
Director, Digital Health Solutions in Global Corporate Strategy & BD, Lundbeck
Beth Wolff has 20+ years experience in healthcare, as a specialist in patient and healthcare research and as a leader within digital therapeutics and digital health tools. She has advised numerous start-ups in digital health, both as a mentor at EIT Health and currently as an Advisory Board Member for a Tanzanian business intelligence provider. At present, Beth is Director, Digital Health Solutions in Global Corporate Strategy & BD at Lundbeck, responsible for developing the global strategy for digital health tools and partnerships for drug discovery, clinical trials, and customer engagement. Prior to joining Lundbeck, she was responsible for developing and commercializing a regulated digital therapeutic product for dementia, was the European Commercial Lead for the Pear Therapeutics partnership with Sandoz, and held various commercial and strategic leadership roles within Novo Nordisk and LEO Pharma. Beth has an MA in Political Economy and is completing an MSc in Public Health at the London School of Hygiene and Tropical Medicine, focusing her final project on developing practical guidelines for digital app developers to increase equity and access to their products.